Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson’s disease in south Indian population
Autor: | Rathika Chinniah, Sasiharan Pandi, Padma Malini Ravi, Vandit Sevak, Balakrishnan Karuppiah, Murali Vijayan, Neethi Arasu Vellaiappan |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
0301 basic medicine Parkinson's disease Genotype Arylamine N-Acetyltransferase India Disease Biology Polymorphism Single Nucleotide Pathogenesis 03 medical and health sciences 0302 clinical medicine medicine Humans Genetic Predisposition to Disease N acetyltransferase 2 Genetic Association Studies Aged Genetics General Neuroscience Acetylation Parkinson Disease Middle Aged medicine.disease 030104 developmental biology Slow acetylator Female Gene polymorphism South indian population 030217 neurology & neurosurgery |
Zdroj: | Neuroscience Letters. 735:135260 |
ISSN: | 0304-3940 |
Popis: | Parkinson's Disease (PD) is a neurodegenerative disorder with predisposing genetic and environmental factors. The present study was undertaken to elucidate the possible association of NAT2 gene polymorphism in PD patients from south India.Using previously validated PCR-RFLP assays, we genotyped 105 PD subjects and 101 healthy controls for N-acetyl transferase (NAT2) gene polymorphism.We observed a significantly elevated frequencies of NAT2 *5/6 (OR = 4.21; p 0.029) and *5/7 (OR = 2.73; p 0.025) genotypes and NAT2*5 (OR = 1.83; p 0.039) allele among PD cases showing susceptible associations. The age at onset analysis revealed a significant association of NAT2 *4/6 (OR = 4.62; p 0.05) genotype with early onset PD (EOPD). A positive association with early onset disease was observed for *5/7 (OR = 3.88; p 0.075) genotype, however without statistical significance. Whereas, in late onset PD (LOPD) cases, significant susceptible association was observed for NAT2 *5/7 (OR = 5.27; p 0.029) genotype. We observed a highly significant protective association of NAT2 *4/6 (OR = 0.27; p 0.012) genotype and NAT2 *4 (OR = 0.52; p 0.027) allele with LOPD. The acetylator status phenotype analysis have revealed a higher risk for, 'NAT2 slow acetylator' in both overall PD (OR = 2.39; p 0.002) and LOPD (OR = 2.88; p 0.007). However, 'NAT2 intermediate acetylator' with a lower risk in both overall PD (OR = 0.47; p 0.011) and LOPD (OR = 0.36; p 0.007) cases revealed protective associations.Thus, our results revealed the possible susceptible association of NAT2 slow acetylator in PD pathogenesis in south Indian population. |
Databáze: | OpenAIRE |
Externí odkaz: |